Newsletter: Vol 8, No. 2, June 2024

In this issue, read about published studies on the provision of telemedicine medication abortion without in-person tests and the use of low-dose oral misoprostol for labor induction in pregnancies complicated by hypertension as well as ongoing research on alternative abortifacients, ‘period pill’ regimens, and a postpartum self-care monitoring app. Also read about a medication abortion training program for pharmacists in Washington and last week's U.S. Supreme Court decision to reject a lawsuit by opponents of abortion.

Read the full Newsletter